nitroblue tetrazolium has been researched along with methotrexate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kohút, A; Mirossay, L; Mojzis, J; Sallingová, Z | 1 |
| Malec, J; Przybyszewski, WM | 1 |
| Bodner, AJ; Gallo, RC; Ting, RC | 1 |
3 other study(ies) available for nitroblue tetrazolium and methotrexate
| Article | Year |
|---|---|
[The role of polymorphonuclear leukocytes in the development of gastric lesions induced by indomethacin and ethanol and the relation of vascular permeability].
Topics: Animals; Capillary Permeability; Ethanol; Female; Gastric Mucosa; Indomethacin; Leukocyte Count; Male; Methotrexate; Neutrophils; Nitroblue Tetrazolium; Pentoxifylline; Rats; Rats, Wistar | 1992 |
Hydroxyurea, methotrexate and adriblastine can mediate non-enzymatic reduction of nitroblue tetrazolium with NADH which is inhibited by superoxide dismutase.
Topics: Antibiotics, Antineoplastic; Doxorubicin; Free Radicals; Hydroxyurea; Methotrexate; NAD; Nitroblue Tetrazolium; Oxidation-Reduction; Superoxide Dismutase; Superoxides; Tetrazolium Salts | 1987 |
Induction of differentiation of human promyelocytic leukemia cells (HL-60) by nucleosides and methotrexate.
Topics: Cell Differentiation; Cell Line; Humans; Kinetics; Leukemia, Myeloid, Acute; Methotrexate; Nitroblue Tetrazolium; Purine Nucleosides; Pyrimidine Nucleosides | 1981 |